3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
6
Colonic Neoplasms
4
Rectal Neoplasms
3
Pancreatic Adenocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Somatostatinoma
1
Salivary Gland Neoplasms
1
Pancreatic Intraductal Neoplasms
1
PRETEXT I Hepatoblastoma
1
Oropharyngeal Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Klatskin Tumor
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Bile Duct Neoplasms
1
Anus Neoplasms
1
Interventions
trametinib
1
dehydroftorafur
1
Sorafenib
1
Self Expandable Metallic Stents
1
Leucovorin
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Drug Therapy
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Klatskin Tumor
×
dehydroftorafur
×
Clear all
NCT02042443
2017-09-12
S1310
National Cancer Institute (NCI)
Phase 2
Completed
53 enrolled
13 charts